New Genital Herpes vaccine entrants require improved efficacy to compete, says GlobalData analyst
31 October 2014 | By GlobalData
While the collaboration between Sanofi Pasteur (Sanofi) and Immune Design to develop a genital herpes vaccine presents a strong scientific foundation and difficult-to-match financial clout, the partnership needs to create a product with better clinical performance to compete with more advanced pipeline vaccine candidates, says an analyst with research and…